Wegovy Reviews: Trial Results, Side Effects & What to Check

A Wegovy review can help you think of questions about treatment. It cannot tell you how likely you are to lose weight, tolerate the medicine or keep paying for it. For those decisions, start with the clinical evidence and your own prescription and coverage details.

This guide reviews published trials and the FDA label. It does not present a collected or verified sample of customer reviews, a patient survey or firsthand product testing. The questions below help you assess an individual account without treating it as a typical outcome.

Most results discussed here concern once-weekly semaglutide 2.4 mg, the injection studied in STEP 1. Wegovy also has an approved daily tablet; its doses and evidence are different¹. Read oral vs injectable semaglutide before applying an injection result to a pill review.

What the trials tell you about weight loss

In STEP 1, adults with overweight or obesity, without diabetes, received weekly semaglutide 2.4 mg or placebo alongside lifestyle intervention. Average weight change at 68 weeks was −14.9% with semaglutide versus −2.4% with placebo². That is a trial average, not an individual promise. The two-year STEP 5 trial reported about 15% average loss at 104 weeks with continued treatment⁵.

When a review gives a result, ask how long the person took the medicine, which formulation and dose they used, and whether they have diabetes. Pounds lost alone leave out the starting weight. A short account also may not describe missed doses, other treatment or changes in eating and activity.

For the early treatment timeline, see when Wegovy starts working. If the scale has stopped moving, take your dose and weight history to the prescriber rather than increasing the dose yourself. Is Wegovy worth it? puts the treatment commitment alongside the evidence.

What the label tells you about side effects

In the FDA label's adult weight-management injection trials, nausea occurred in 44% of Wegovy participants versus 16% with placebo; diarrhea in 30% versus 16%; and constipation in 24% versus 11%¹. Those are trial rates for the injection, not percentages calculated from online reviews.

An account of nausea can be useful when it explains timing, severity and the response from the care team. It cannot establish that the same symptom will happen to you. Equally, a person who tolerates treatment well does not show that serious reactions are impossible. Persistent or severe symptoms deserve clinical advice; severe abdominal pain that does not go away requires prompt attention¹.

Our guides cover semaglutide dosing and side effects, Wegovy constipation and diarrhea and hair loss during treatment. Use them to prepare questions for the prescriber, not to dismiss symptoms because a reviewer calls them normal.

How to assess a review of the weekly injection

Look for the exact pen and the instructions the person received. Someone else's confidence or discomfort with a needle does not predict yours. Ask the clinician or pharmacist to demonstrate your prescribed device and explain what to do if a dose seems incomplete.

Start with how to inject Wegovy and injection-site guidance. A review of the pill involves a different daily routine, so keep it separate from accounts of weekly injections.

What happens after stopping?

The STEP 1 extension followed a subset of participants after semaglutide and the trial lifestyle intervention ended. Over the following year, the semaglutide group regained about two-thirds of its previous weight loss on average; many cardiometabolic measures moved back toward baseline³. This is evidence that maintaining benefit may require ongoing treatment. It does not mean every person regains the same amount.

When reading a longer-term report, check whether the writer is still taking Wegovy. If treatment stopped, ask when, why, and what support or other treatment followed. We have not measured how often online reviews include that follow-up. See stopping semaglutide and weight regain after stopping for the evidence and planning questions.

Benefits a star rating cannot establish

SELECT studied adults aged 45 or older with established cardiovascular disease and overweight or obesity, without diabetes. Weekly semaglutide reduced major cardiovascular events compared with placebo⁴. That finding applies to a defined study population. A person's report of feeling better cannot establish their cardiovascular risk reduction.

For that distinction, read Wegovy and Ozempic heart benefits. Comparisons with another drug need their own evidence: see Ozempic vs Wegovy and switching from Zepbound to Wegovy, rather than converting doses from a review.

Confirm the medicine and the service being reviewed

Branded Wegovy and compounded semaglutide are different products. Compounded drugs are not FDA-approved and do not receive FDA review for safety, effectiveness and quality before marketing⁶. A review of a compounded vial is not evidence about the Wegovy pen or tablet. Our brand-versus-compounded comparison explains the distinction.

Also separate the medicine from the provider. Billing, appointment access, pharmacy delivery and cancellation describe a service. They do not prove whether the drug works. Check the relevant provider review, including Ro, Hims or Found, for the program details. Noom and Calibrate also have distinct care and membership models.

Five checks before relying on an account

• •Product: Was it a Wegovy pen, approved tablet or compounded product?
• •Dose and duration: How long did treatment last, and which dose was reached?
• •Result: Is weight change given with starting weight and a time period?
• •Safety and follow-up: What symptoms occurred, what care was sought, and is treatment continuing?
• •Service and cost: Does the account distinguish medication from visits, delivery and membership fees?

Turning reviews into a treatment decision

Bring the questions a review raises to your clinician. Use trials for measured outcomes and the label for approved use and safety information. A review can describe one person's experience; it cannot give you a reliable personal forecast.

Before paying, compare Wegovy cost and savings, insurance coverage and what happens when you buy online. Our provider comparison helps identify what each program includes. For the broader clinical picture, start with semaglutide: results and side effects.